REFERENCES
- Olah , M. E. and Stiles , G. L. 2000 . The role of receptor structure in determining adenosine receptor activity . Pharmacol. Ther. , 85 : 55 – 75 .
- Jacobson , K. A. and Gao , Z.-G. 2006 . Adenosine receptors as therapeutic targets . Nature Rev. Drug Dis. , 5 : 247 – 264 .
- Baraldi , P. G. , Cacciari , B. , Romagnoli , R. , Merighi , S. , Varani , K. , Borea , P. A. and Spalluto , G. 2000 . A3 Adenosine receptor ligands: History and perspectives . Med. Res. Rev. , 20 : 103 – 128 .
- Kim , H. O. , Ji , X.-D. , Siddiqi , S. M. , Olah , M. E. , Stiles , G. L. and Jacobson , K. A. 1994 . 2-Substitution of N 6-benzyladenosine-5′ -uronamides enhances selectivity for A3-adenosine receptors . J. Med. Chem. , 37 : 3614 – 3621 .
- Jeong , L. S. , Lee , H. W. , Jacobson , K. A. , Kim , H. O. , Shin , D. H. , Lee , J. A. , Gao , Z.-G. , Lu , C. , Duong , H. T. , Gunaga , P. , Lee , S. K. , Jin , D. Z. , Chun , M. W. and Moon , H. R. 2006 . Structure-activity relationship of 2-chloro-N 6-substituted-4′-thioadenosine-5′-uronamides as highly potent and selective agonists at the human A3 adenosine receptor . J. Med.Chem. , 49 : 273 – 281 .
- Gao , Z.-G. , Joshi , B. V. , Klutz , A. M. , Kim , S. K. , Lee , H. W. , Kim , H. O. , Jeong , L. S. and Jacobson , K. A. 2006 . Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moiety . Bioorg. Med. Chem. Lett. , 16 : 596 – 601 .
- Lee , E. J. , Min , H. Y. , Chung , H. J. , Park , E. J. , Shin , D. H. , Jeong , L. S. and Lee , S. K. 2005 . A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells . Biochem. Pharmacol. , 70 : 918 – 924 .